340B Health

Who We Are

340B Health represents public and private nonprofit hospitals and health systems that participate in the 340B drug discount program.

Learn more about us

340B Informed

Senators Ask GAO: Are Manufacturers Gaming the Orphan Drug System?

March 22, 2017—The Government Accountability Office is investigating whether drug manufacturers are abusing the Orphan Drug Act for profit....
Read More

HHS Mulls Pushing Back 340B Ceiling Price Rule to Oct. 1

March 17, 2017 – The Health Resources and Services Administration has again pushed back the effective date of its 340B ceiling price and manufacturer civil monetary penalties regulation, from March 21 to May 22, and is inviting comment on whether a longer delay to Oct. 1 “would be more appropriate.”...
Read More

The Exchange